Cargando…

HER1 R497K and HER2 I655V Polymorphisms Are Linked to Development of Breast Cancer

BACKGROUND: Polymorphism of the genes of Human Epidermal growth factor receptor1 (HER1) and receptor2 (HER2) have been reported to be linked to pathogenesis of several malignant tumors but still there is contradiction regarding their association with breast cancer. OBJECTIVE: In this case control st...

Descripción completa

Detalles Bibliográficos
Autores principales:	AbdRaboh, Naglaa R., Shehata, Hanan H., Ahmed, Manal B., Bayoumi, Fatehia A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2013
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810125/ https://www.ncbi.nlm.nih.gov/pubmed/23594562 http://dx.doi.org/10.3233/DMA-130989

Ejemplares similares

HER2 Ile655Val Single Nucleotide Polymorphism in Patients with Ovarian Cancer
por: Mojtahedi, Zahra, et al.
Publicado: (2013)

Design and characterization of a SYBR Green I-based melting curve method for investigation of HER2I655V polymorphism in breast cancer
por: Desriani, et al.
Publicado: (2021)

Dataset reporting detection of breast cancer-related HER2(I655V) polymorphism using allele-specific polymerase chain reaction
por: Budiarto, Bugi Ratno, et al.
Publicado: (2016)

A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer
por: Nelson, Stephanie E, et al.
Publicado: (2005)

Influence of Ile655Val polymorphism on trastuzumab-induced cardiotoxicity in early-stage HER2 positive breast cancer
por: Vazdar, Ljubica, et al.
Publicado: (2021)

Her2(Ile)655(Val) polymorphism and its association with breast cancer risk: an updated meta-analysis of case-control studies
por: Krishna, B. Madhu, et al.
Publicado: (2018)

HER2(Ile655Val) Single Nucleotide Polymorphism Associated with Early-Onset Breast Cancer Susceptibility: A Systematic Review and Meta-Analysis
por: Thanh, Tung Nguyen, et al.
Publicado: (2021)

BCL-2 (-938C>A), BAX (-248G>A), and HER2 Ile655Val Polymorphisms and Breast Cancer Risk in Indian Population
por: Bhatt, Deepti, et al.
Publicado: (2021)

Alleviation of Antioxidant Defense System by Ozonized Olive Oil in DNBS-Induced Colitis in Rats
por: Abu-Gharbieh, Eman, et al.
Publicado: (2014)

Impact of phenolic composition on hepatoprotective and antioxidant effects of four desert medicinal plants
por: Shehab, Naglaa Gamil, et al.
Publicado: (2015)

Comparison between Real-Time Quantitative PCR Detection of HER2 mRNA Copy Number in Peripheral Blood and ELISA of Serum HER2 Protein for Determining HER2 Status in Breast Cancer Patients
por: Savino, Maria, et al.
Publicado: (2009)

Expression of HER2 in Colorectal Cancer Does Not Correlate with Prognosis
por: Kruszewski, Wiesław Janusz, et al.
Publicado: (2010)

655Val and 1170Pro ERBB2 SNPs in Familial Breast Cancer Risk and BRCA1 Alterations
por: Tommasi, Stefania, et al.
Publicado: (2007)

Lunch with the FT: A world of her own
por: Pincock, Stephen
Publicado: (2005)

Validation of a Fully Automated HER2 Staining Kit in Breast Cancer
por: Moelans, Cathy B., et al.
Publicado: (2010)

Expression Profile of Tyrosine Phosphatases in HER2 Breast Cancer Cells and Tumors
por: Lucci, Maria Antonietta, et al.
Publicado: (2010)

Immunohistochemiluminescence Detection: A Quantitative Tool in Breast Cancer HER-2 Status Evaluation
por: Rêgo, Moacyr Jesus Barreto de Melo, et al.
Publicado: (2013)

Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients
por: Sobral-Leite, Marcelo, et al.
Publicado: (2017)

Metastatic Breast Cancer Survival according to HER2 and Topo2a Gene Status
por: Todorović-Raković, N., et al.
Publicado: (2009)

ODP655 Apathetic Hyperthyroidism
por: Seetharaman, Kavita
Publicado: (2022)

Why Do I Love Her
Publicado: (1892)

R497K polymorphism in epidermal growth factor receptor gene is associated with the risk of acute coronary syndrome
por: Gao, Lin-Bo, et al.
Publicado: (2008)

HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship with Response to Neoadjuvant Anti-HER2 Treatment
por: Novillo, Apolonia, et al.
Publicado: (2023)

HER kinase inhibition in patients with HER2- and HER3-mutant cancers
por: Hyman, David M., et al.
Publicado: (2018)

Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients
por: Sassen, Andrea, et al.
Publicado: (2008)

Tyrosine Phosphatases in the HER2-Directed Motility of Ovarian Cancer Cells: Involvement of PTPN12, ERK5 and FAK
por: Villa-Moruzzi, Emma
Publicado: (2011)

Evaluation of C-ErbB-2 Overexpression and Her-2/neu Gene Copy Number Heterogeneity in Barrett’s Adenocarcinoma
por: Walch, Axel, et al.
Publicado: (2000)

HER2-PI9 and HER2-I12: two novel and functionally active splice variants of the oncogene HER2 in breast cancer
por: Hart, Vic, et al.
Publicado: (2021)

Phase I clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
por: Hamilton, Erika, et al.
Publicado: (2012)

Association between the Arg72Pro Genotypes in the TP53 Gene and Ile655Val in the HER2 Gene and the Risk of Developing Breast Cancer in the Population of Amapá, Northern Brazil
por: Cardoso, Yasmin Maria Nunes, et al.
Publicado: (2023)

HER2 Expression in Gastric Cancer: Rare, Heterogeneous and of No Prognostic Value – Conclusions from 924 Cases of Two Independent Series
por: Grabsch, Heike, et al.
Publicado: (2010)

HER-2/neu Amplification Testing in Breast Cancer by Multiplex Ligation-Dependent Probe Amplification in Comparison with Immunohistochemistry and In Situ Hybridization
por: Moelans, Cathy B., et al.
Publicado: (2009)

The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
por: Majumder, Avisek, et al.
Publicado: (2021)

MicroRNA-655-3p and microRNA-497-5p inhibit cell proliferation in cultured human lip cells through the regulation of genes related to human cleft lip
por: Gajera, Mona, et al.
Publicado: (2019)

Model-Based Analysis of HER Activation in Cells Co-Expressing EGFR, HER2 and HER3
por: Shankaran, Harish, et al.
Publicado: (2013)

The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients
por: Memon, A A, et al.
Publicado: (2006)

MIR497HG‐Derived miR‐195 and miR‐497 Mediate Tamoxifen Resistance via PI3K/AKT Signaling in Breast Cancer
por: Tian, Yao, et al.
Publicado: (2023)

“Everything for Her!”
por: Andrijević Matovac, Vesna
Publicado: (2011)

In her family /
por: Metheny, Pat
Publicado: (1987)

ADVICE TO THE EXPECTANT MOTHER ON THE CARE OF HER HEALTH AND THAT OF HER CHILD
Publicado: (1947)

Cannot write session to /tmp/vufind_sessions/sess_go94mhcsddb5fgdid360f1h654